Yanling Feng Selected Research

Yanling Feng Research Topics

Disease

35	Neoplasms (Cancer) 11/2023 - 01/2012
18	Infections 08/2023 - 10/2012
15	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2015
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2024 - 04/2015
8	Inflammation (Inflammations) 02/2024 - 01/2015
7	Pneumonia (Pneumonitis) 02/2024 - 09/2016
7	Chronic Hepatitis B 01/2022 - 11/2015
6	Ovarian Epithelial Carcinoma 01/2021 - 01/2012
5	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2015
4	Non-alcoholic Fatty Liver Disease 05/2023 - 01/2023
4	Carcinoma (Carcinomatosis) 01/2023 - 04/2015
4	Disease Progression 12/2022 - 01/2020
4	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2015
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 05/2010
3	Colorectal Neoplasms (Colorectal Cancer) 09/2022 - 01/2015
3	HIV Infections (HIV Infection) 09/2022 - 01/2017
3	Carcinogenesis 01/2022 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2019
3	Hepatitis 01/2022 - 09/2021
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 03/2018
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2018
3	Liver Diseases (Liver Disease) 09/2021 - 01/2011
3	Fibrosis (Cirrhosis) 05/2021 - 01/2020
2	COVID-19 01/2023 - 01/2020
2	Dysbiosis 01/2023 - 01/2023
2	Acquired Immunodeficiency Syndrome (AIDS) 09/2022 - 01/2018
2	Colitis 01/2022 - 01/2017
2	Ascites 01/2021 - 01/2012
2	Neoplasm Metastasis (Metastasis) 06/2020 - 03/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 01/2016
2	Endometrial Neoplasms (Endometrial Cancer) 12/2014 - 04/2013
1	Communicable Diseases (Infectious Diseases) 12/2024
1	Bone Resorption 03/2024
1	Osteoporosis 03/2024
1	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2024
1	Acute Kidney Injury (Acute Renal Failure) 12/2023
1	Alzheimer Disease (Alzheimer's Disease) 10/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2023
1	Atherosclerosis 09/2023
1	Sepsis (Septicemia) 06/2023

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 03/2024 - 05/2010
15	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2010
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2020
6	PlatinumIBA 12/2022 - 10/2017
5	MicroRNAs (MicroRNA)IBA 09/2023 - 01/2017
5	Anti-Bacterial Agents (Antibiotics)IBA 08/2023 - 09/2016
5	Messenger RNA (mRNA)IBA 09/2022 - 01/2015
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 08/2018
4	CytokinesIBA 01/2023 - 01/2012
4	RNA (Ribonucleic Acid)IBA 09/2022 - 01/2015
4	AntigensIBA 01/2022 - 03/2013
4	CollagenIBA 09/2021 - 03/2012
3	Virulence Factors (Pathogenicity Factors)IBA 06/2023 - 08/2021
3	Ethanol (Ethyl Alcohol)IBA 05/2023 - 01/2011
3	LipidsIBA 01/2023 - 02/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2018
3	niraparibIBA 12/2022 - 01/2020
3	Hepatitis B e AntigensIBA 01/2022 - 12/2020
3	Circular RNAIBA 11/2020 - 01/2020
3	ProteomeIBA 06/2012 - 05/2010
2	16S Ribosomal RNAIBA 12/2024 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 02/2024
2	Carboplatin (JM8)FDA LinkGeneric 03/2024 - 04/2013
2	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 12/2023
2	Phosphotransferases (Kinase)IBA 02/2024 - 01/2020
2	LipopolysaccharidesIBA 02/2024 - 09/2022
2	Amyloid (Amyloid Fibrils)IBA 10/2023 - 12/2022
2	oxidized low density lipoproteinIBA 09/2023 - 02/2012
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 03/2018
2	Sirtuin 2IBA 12/2022 - 01/2021
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2018
2	NAD (NADH)IBA 01/2022 - 01/2021
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 11/2021 - 01/2020
2	Sirtuin 1IBA 01/2021 - 01/2020
2	Nucleic AcidsIBA 12/2020 - 03/2016
2	Competitive Endogenous RNAIBA 10/2020 - 01/2020
2	C-Reactive ProteinIBA 01/2020 - 02/2012
2	AlbuminsIBA 01/2020 - 01/2015
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2019 - 10/2017
2	Interleukin-13IBA 01/2017 - 10/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2015 - 03/2012
1	puerarinIBA 03/2024
1	Monoclonal AntibodiesIBA 03/2024
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2024
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2023
1	Dichlorodiphenyldichloroethane (DDD)IBA 11/2023
1	HMGB1 Protein (HMG1)IBA 09/2023
1	capsular-polysaccharide galactohydrolaseIBA 08/2023

Therapy/Procedure

15	Therapeutics 02/2024 - 06/2014
9	Drug Therapy (Chemotherapy) 03/2024 - 01/2012
5	Neoadjuvant Therapy 01/2021 - 10/2016
3	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 06/2020
3	Hysterectomy 01/2023 - 04/2015
3	Cytoreduction Surgical Procedures 01/2022 - 01/2015
2	Immunotherapy 12/2023 - 01/2019
2	Lasers (Laser) 08/2023 - 01/2012
2	Radiotherapy 01/2023 - 04/2013
2	Phage Therapy 01/2023 - 10/2022
2	Adjuvant Chemotherapy 12/2014 - 04/2013
1	TP protocol 03/2024